Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Emilie Wahren, Borgström"'
Autor:
Ola Hammarsten, Anna Lyytikäinen, Sofia Thunström, Torben Ek, Anders Fasth, Olov Ekwall, Sara Cajander, Emilie Wahren Borgström, C. I. Edvard Smith, Pegah Johansson
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background DNA repair deficiency disorders are rare inherited diseases arising from pathogenic (disease-causing) variants in genes involved in DNA repair. There are no standardized diagnostic assays for the investigation of pathological sign
Externí odkaz:
https://doaj.org/article/75b1d9d18bce47b7b32a1fc70bdab469
Autor:
Peter Bergman, MD, Ola Blennow, MD, Lotta Hansson, MD, Stephan Mielke, MD, Piotr Nowak, MD, Puran Chen, MD, Gunnar Söderdahl, MD, Anders Österborg, MD, C. I. Edvard Smith, MD, David Wullimann, MSc, Jan Vesterbacka, MD, Gustaf Lindgren, MD, Lisa Blixt, MD, Gustav Friman, MD, Emilie Wahren-Borgström, MD, Anna Nordlander, MD, Angelica Cuapio Gomez, MD, Mira Akber, MSc, Davide Valentini, MD, Anna-Carin Norlin, MD, Anders Thalme, MD, Gordana Bogdanovic, MD, Sandra Muschiol, PhD, Peter Nilsson, PhD, Sophia Hober, PhD, Karin Loré, PhD, Margaret Sällberg Chen, PhD, Marcus Buggert, PhD, Hans-Gustaf Ljunggren, MD, Per Ljungman, MD, Soo Aleman, MD
Publikováno v:
EBioMedicine, Vol 74, Iss , Pp 103705- (2021)
Background: Patients with immunocompromised disorders have mainly been excluded from clinical trials of vaccination against COVID-19. Thus, the aim of this prospective clinical trial was to investigate safety and efficacy of BNT162b2 mRNA vaccination
Externí odkaz:
https://doaj.org/article/4718ffd4f65749848e9d9b7f48c73d1b
Autor:
Gabrielle Fröberg, Emilie Wahren Borgström, Erja Chryssanthou, Margarida Correia-Neves, Gunilla Källenius, Judith Bruchfeld
Publikováno v:
ERJ Open Research, Vol 5, Iss 2 (2019)
Tuberculosis (TB) elimination programmes need to target preventive treatment to groups with an increased risk of TB activation, such as individuals with a latent tuberculosis infection (LTBI) acquired recently. Current diagnostic tests for LTBI have
Externí odkaz:
https://doaj.org/article/8bd3c4cbe3aa4d0ab80ed0a6fc1313da
Autor:
Emilie Wahren Borgström, Marie Edvinsson, Lucia Pena Perez, Anna-Carin Norlin, Susanne Hansen, Anders Fasth, Vanda Friman, Olle Kämpe, Robert Månsson, Ziyang Tan, Carl Inge Edvard Smith, Petter Brodin, Peter Bergman
Purpose: The aim of this study was to characterize biomarkers in three patients with chronic mucocutaneous candidiasis caused by gain of function mutations in the STAT1 gene during treatment with Janus kinase inhibitors. Methods: We used mass cytomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61f0a7abdee79e46d4bb296716cf77e1
https://doi.org/10.21203/rs.3.rs-1404924/v1
https://doi.org/10.21203/rs.3.rs-1404924/v1
Autor:
Anna-Carin Norlin, Susanne Hansen, Emilie Wahren-Borgström, Carl Granert, Linda Björkhem-Bergman, Peter Bergman
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163451 (2016)
BACKGROUND:Vitamin D supplementation has been proposed to improve clinical symptoms during respiratory tract infections (RTIs), but results from randomized, placebo-controlled trials (RCT) are inconclusive. Previously, we performed an RCT in patients
Externí odkaz:
https://doaj.org/article/eec44aa5eda34239be85dd6d29d2de56
Autor:
Peter, Bergman, David, Wullimann, Yu, Gao, Emilie, Wahren Borgström, Anna-Carin, Norlin, Sara, Lind Enoksson, Soo, Aleman, Hans-Gustaf, Ljunggren, Marcus, Buggert, C I Edvard, Smith
Publikováno v:
Journal of clinical immunology. 42(4)
Limited data is available on the effect of COVID-19 vaccination in immunocompromised individuals. Here, we provide the results from vaccinating a single-center cohort of patients with common variable immunodeficiency (CVID).In a prospective, open-lab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ad2a2b4ebeec4b79069db628dfd4a29
https://pubmed.ncbi.nlm.nih.gov/35290571
https://pubmed.ncbi.nlm.nih.gov/35290571
Autor:
Ola Hammarsten, Anna Lyytikäinen, Sofia Thunström, Torben Ek, Anders Fasth, Olov Ekwall, Sara Cajander, Emilie Wahren Borgström, C. I. Edvard Smith, Pegah Johansson
Publikováno v:
Orphanet journal of rare diseases. 17(1)
Background DNA repair deficiency disorders are rare inherited diseases arising from pathogenic (disease-causing) variants in genes involved in DNA repair. There are no standardized diagnostic assays for the investigation of pathological significance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab97b5ad035ac8efd3be71162f90cbe7
https://pubmed.ncbi.nlm.nih.gov/35164800
https://pubmed.ncbi.nlm.nih.gov/35164800
Autor:
Soo Aleman, Anna Nordlander, David J. Wullimann, Peter Bergman, Gustaf Lindgren, Gordana Bogdanovic, Davide Valentini, Margaret Chen, Mira Akber, Anders Österborg, C. I. Edvard Smith, Sandra Muschiol, Ola Blennow, Peter Nilsson, Gustav Friman, Sophia Hober, Anders Thalme, Stephan Mielke, Jan Vesterbacka, Anna-Carin Norlin, Angelica Cuapio Gomez, Hans-Gustav Ljunggren, Lotta Hansson, Emilie Wahren Borgström, Per Ljungman, Piotr Nowak, Lisa Blixt, Puran Chen, Gunnar Söderdahl, Karin Loré, Marcus Buggert
Publikováno v:
EBioMedicine
EBioMedicine, Vol 74, Iss, Pp 103705-(2021)
EBioMedicine, Vol 74, Iss, Pp 103705-(2021)
BackgroundPatients with immunocompromised disorders have mainly been excluded from clinical trials of vaccination against COVID-19. Thus, the aim of this prospective clinical trial was to investigate the safety and efficacy after two doses of BNT162b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d809e0fc793f2d26e34f861826bca6
https://doi.org/10.1101/2021.09.07.21263206
https://doi.org/10.1101/2021.09.07.21263206
Autor:
Emilie Wahren, Borgström, Gabrielle, Fröberg, Margarida, Correia-Neves, Fredrik Bosdotter, Atterfelt, Jan, Bellbrant, Robert, Szulkin, Erja, Chryssanthou, Kristian, Ängeby, Teghesti, Tecleab, Morten, Ruhwald, Peter, Andersen, Gunilla, Källenius, Judith, Bruchfeld
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 123
Interferon-γ release assays cannot differentiate latent from active tuberculosis (TB), nor identify the recently infected with increased risk of active disease. The objective of this study was to identify biomarkers of recent infection following exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffe41b3aac3ec6b21569e14e77a13fae
https://pubmed.ncbi.nlm.nih.gov/32741535
https://pubmed.ncbi.nlm.nih.gov/32741535
Autor:
Inger Julander, Gunilla Källenius, Lena Andersson, Maria Norrby, Peter Andersen, Emilie Wahren Borgström, Hans Gaines, Judith Bruchfeld, Ida Rosenkrands, Markus Maeurer, Teghesti Tecleab
Publikováno v:
Journal of Immunological Methods. 370:55-64
There is a large and growing worldwide need for reliable tests to diagnose active and latent tuberculosis (TB). Improved methodology for identifying individuals with true latent TB (LTBI), particularly those with a recent infection, would pave the wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::861ed59cb5f4f8455b53b24ce7f5c359
https://doi.org/10.1016/j.jim.2011.05.008
https://doi.org/10.1016/j.jim.2011.05.008